nach oben

Wiener Medizinische Wochenschrift

Erschienen in:

26.09.2016 | brief report

Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences

verfasst von: Prof. Dr. med. Sascha Meyer, Prof. Dr. med. Ludwig Gortner, NeoVitaA Trial investigators

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 11-12/2017

Einloggen, um Zugang zu erhalten

Summary

The aim of the NeoVitaA Trial is to assess the role of postnatal additional high-dose oral vitamin A supplementation for 28 days in reducing Bronchopulmonary dysplasia (BPD) or death in extremely low birth weight (ELBW) infants at 36 weeks postmenstrual age (PMA). All infants (both intervention and control group) will be provided with basic vitamin A (1000 IU/kg/day) in addition to trial intervention.

In this short communication, we will give an up-date on obstacles, challenges as well as perspectives and potential solutions when putting into place a multicenter, double-blind, randomized trial in this cohort of extremely susceptible infants.

Vorheriger Artikel Acute osteomyelitis and septic arthritis in children

Nächster Artikel ESPED-Erhebung: TSC-Erkrankung bei Kindern und Jugendlichen: eine einjährige Interim-Analyse

Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.CrossRefPubMed

Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF, Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the Trial of Indomethacin Prophylaxis in Preterms. JAMA. 2003;289:1124–9.CrossRefPubMed

Marter LJ van, Kuban KC, Allred E, Bose C, Dammann O, O’Shea M, Laughon M, Ehrenkranz RA, Schreiber MD, Karna P, Leviton A, ELGAN Study Investigators. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed. 2011;96:F20–F29.CrossRefPubMed

Stichtenoth G, Demmert M, Bohnhorst B, Stein A, Ehlers S, Heitmann F, Rieger-Fackeldey E, Olbertz D, Roll C, Emeis M, Mögel M, Schiffmann H, Wieg C, Wintgens J, Herting E, Göpel W, Härtel C. Major contributors to hospital mortality in very-low-birth-weight infants: data of the birth year 2010 cohort of the German Neonatal Network. Klin Padiatr. 2012;224:276–81.CrossRefPubMed

Gortner L, Misselwitz B, Milligan D, et al. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology. 2011;99:112–7.CrossRefPubMed

Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ, Richardson DK. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr. 2005;146:469–73.CrossRefPubMed

Thomas W, Speer CP. Management of infants with bronchopulmonary dysplasia in Germany. Early Hum Dev. 2005;81:155–63.CrossRefPubMed

Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Overmeire B van, Jonsson B, Hallman M, Baldassarre J, EUNO Study Group. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet. 2010;376:346–54.CrossRefPubMed

Watterberg KL, American Academy of Pediatrics. Committee on fetus and newborn policy statement – postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics. 2010;126:800–8.CrossRefPubMed

10.

Röhr SB, Sauer H, Gortner L, Gräber S, Meyer S. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience. Acta Paediatr. 2013;102:e436.CrossRefPubMed

11.

Biesalski HK, Nohr I. Importance of vitamin A for lung function and development. Mol Aspects Med. 2003;24:431–40.CrossRefPubMed

12.

Metzler MD, Snyder JM. Retinoic acid differentially regulates expression of surfactant associated proteins in human fetal lung. Endocrinology. 1993;133:1990–8.CrossRefPubMed

13.

Zile MH. Function of vitamin A in vertebrate embryonic development. J Nutr. 2001;131:705–8.PubMed

14.

Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev. 2011;10:CD000501.

15.

Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, Fanaroff AA. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med. 1999;340:1962–8.CrossRefPubMed

16.

Kaplan HC, Tabangin ME, McClendon D, Meinzen-Derr J, Margolis PA, Donovan EF. Understanding variation in vitamin A supplementation among NICUs. Pediatrics. 2010;126:e367–e373.CrossRefPubMed

17.

Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2009;50:85–91.CrossRef

18.

Wardle SP, Hughes A, Chen S, Shaw NJ. Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F9–F13.CrossRefPubMedPubMedCentral

19.

Gadhia MM, Cutter GR, Abman SH, Kinsella JP. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr. 2014;164:744–8.CrossRefPubMed

20.

Meyer S, Gortner L. NeoVitaA Trial Investigators Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Neonatology. 2014;105:182–8.CrossRefPubMed

Titel: Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences
verfasst von: Prof. Dr. med. Sascha Meyer
Prof. Dr. med. Ludwig Gortner
NeoVitaA Trial investigators
Publikationsdatum: 26.09.2016
Verlag: Springer Vienna
Erschienen in: Wiener Medizinische Wochenschrift / Ausgabe 11-12/2017
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI: https://doi.org/10.1007/s10354-016-0500-z

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11-12/2017

The role of EEG recordings in children undergoing cardiac surgery for congenital heart disease

Editorial

The role and limitations of Cochrane reviews at the bedside: a systematic synopsis of five pediatric subspecialties

Role of multiplex PCR analysis in children with febrile seizures

Acute osteomyelitis and septic arthritis in children

An unusual cause of vertigo and headache in childhood